CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3026% above fair value
$74.56+0.84 (+1.14%)
Close on Nov 17, 2026Market cap $3.92BP/E 31.2Yield –
CareDx operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
CareDx's operating income for the twelve months ending Sep 30, 2026 was $116.49M, up 95.3% year over year. For fiscal 2025 it was -$30.78M, down 175.5% from the year before. The highest annual figure on record is $40.77M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$30.78M | -175.5% |
| FY2024 | Dec 31, 2024 | $40.77M | – |
| FY2023 | Dec 31, 2023 | -$203.36M | – |
| FY2022 | Dec 31, 2022 | -$77.23M | – |
| FY2021 | Dec 31, 2021 | -$29.73M | – |
| FY2020 | Dec 31, 2020 | -$22.53M | – |
| FY2019 | Dec 31, 2019 | -$24.53M | – |
| FY2018 | Dec 31, 2018 | -$15.58M | – |
| FY2017 | Dec 31, 2017 | -$20.29M | – |
| FY2016 | Dec 31, 2016 | -$37.33M | – |
| FY2015 | Dec 31, 2015 | -$11.93M | -1054.6% |
| FY2014 | Dec 31, 2014 | $1.25M | – |
| FY2013 | Dec 31, 2013 | -$857.00K | – |
| FY2012 | Dec 31, 2012 | -$2.34M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.11M | – |
| Q2 FY2026 | Jun 30, 2026 | $113.22M | – |
| Q1 FY2026 | Mar 31, 2026 | $1.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.04M | -107.2% |
| Q3 FY2025 | Sep 30, 2025 | -$246.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$11.12M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.37M | – |
| Q4 FY2024 | Dec 31, 2024 | $84.38M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.72M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.57M | – |
| Q4 FY2023 | Dec 31, 2023 | -$122.63M | – |
| Q3 FY2023 | Sep 30, 2023 | -$28.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$27.62M | – |
| Q1 FY2023 | Mar 31, 2023 | -$24.32M | – |
| Q4 FY2022 | Dec 31, 2022 | -$19.12M | – |
| Q3 FY2022 | Sep 30, 2022 | -$17.34M | – |
| Q2 FY2022 | Jun 30, 2022 | -$21.72M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.05M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.40M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.73M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.74M | – |
| Q1 FY2021 | Mar 31, 2021 | -$858.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.07M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.91M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.80M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.75M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.55M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.75M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.84M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.40M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.42M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.72M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.21M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.24M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.29M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.86M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.60M | – |
| Q1 FY2017 | Mar 31, 2017 | -$8.54M | – |
| Q4 FY2016 | Dec 31, 2016 | -$18.86M | – |
See a number that looks wrong?